diphenylcyclopropenone has been researched along with Vitiligo in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grimes, PE; Nashawati, R | 1 |
Goh, BK; Lee, J; Pan, JY; Theng, C | 1 |
Campanati, A; Ganzetti, G; Giuliodori, K; Offidani, A; Simonetti, O | 1 |
Lee, MH; Oh, YJ; Shin, MK | 1 |
Bakker, JG; Bos, JD; Hosseinpour, D; Luiten, RM; van der Veen, JP; Vrijman, C; Wolkerstorfer, A | 1 |
Henderson, CA; Ilchyshyn, A | 1 |
Brahams, D | 1 |
Duhra, P; Foulds, IS | 1 |
Cotterill, JA; MacDonald-Hull, SP; Norris, JF | 1 |
Orecchia, G; Perfetti, L | 1 |
Gourgiotou, K; Hatzis, J; Stratigos, J; Tosca, A; Varelzidis, A | 1 |
1 review(s) available for diphenylcyclopropenone and Vitiligo
Article | Year |
---|---|
Depigmentation Therapies for Vitiligo.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anisoles; Body Surface Area; Cryotherapy; Cyclopropanes; Humans; Hydroquinones; Imatinib Mesylate; Imiquimod; Low-Level Light Therapy; Patient Selection; Phenol; Protein Kinase Inhibitors; Severity of Illness Index; Skin Lightening Preparations; Vitiligo | 2017 |
10 other study(ies) available for diphenylcyclopropenone and Vitiligo
Article | Year |
---|---|
Vitiligo as an adverse reaction to topical diphencyprone.
Topics: Administration, Topical; Aged; Child; Cyclopropanes; Female; Haptens; Humans; Male; Middle Aged; Vitiligo | 2009 |
Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo.
Topics: Adult; Alopecia Areata; Cyclopropanes; Humans; Male; Radiation Dosage; Treatment Outcome; Ultraviolet Therapy; Vitiligo | 2010 |
Narrow-band ultraviolet B treatment for diphenylcyclopropenone-induced vitiliginous lesions.
Topics: Adolescent; Adult; Alopecia Areata; Cyclopropanes; Drug Eruptions; Female; Humans; Male; Ultraviolet Therapy; Vitiligo; Warts | 2012 |
Provoking factors, including chemicals, in Dutch patients with vitiligo.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Captan; Cohort Studies; Cyclopropanes; Female; Humans; Male; Middle Aged; Phenols; Retrospective Studies; Risk Factors; Solvents; Stress, Psychological; Sunburn; Sunlight; Surveys and Questionnaires; Vitiligo; Young Adult | 2013 |
Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis.
Topics: Adult; Alopecia Areata; Cyclopropanes; Drug Eruptions; Humans; Male; Scalp Dermatoses; Vitiligo | 1995 |
Expert witnesses and experimental treatment: the extent of the duty to warn of risks when using experimental treatment.
Topics: Alopecia; Cyclopropanes; Duty to Warn; Expert Testimony; Female; Human Experimentation; Humans; Informed Consent; Risk Factors; United Kingdom; Vitiligo | 2001 |
Persistent vitiligo induced by diphencyprone.
Topics: Adult; Alopecia; Cyclopropanes; Humans; Male; Vitiligo | 1990 |
Vitiligo following diphencyprone dermatitis.
Topics: Cyclopropanes; Drug Eruptions; Female; Humans; Middle Aged; Vitiligo | 1989 |
Vitiligo and topical allergens.
Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclopropanes; Humans; Vitiligo | 1989 |
Vitiligo as a reaction to topical treatment with diphencyprone.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Female; Humans; Male; Middle Aged; Vitiligo | 1988 |